Cargando…
Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis
INTRODUCTION: The emergence of multidrug-resistant (MDR) Mycobacterium tuberculosis (Mtb) posed a severe challenge to tuberculosis (TB) management. The treatment of MDR-TB involves second-line anti-TB agents, most of which are injectable and highly toxic. Previous metabolomics study of the Mtb membr...
Autores principales: | Shao, Zitong, Chow, Michael Y. T., Chow, Shing Fung, Lam, Jenny K. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984245/ https://www.ncbi.nlm.nih.gov/pubmed/36869245 http://dx.doi.org/10.1007/s11095-023-03488-y |
Ejemplares similares
-
Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy
por: Shao, Zitong, et al.
Publicado: (2021) -
Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strategies for Translational Research
por: Chan, Ho Wan, et al.
Publicado: (2023) -
Rifampin- or Capreomycin-Induced Remodeling of the Mycobacterium smegmatis Mycolic Acid Layer Is Mitigated in Synergistic Combinations with Cationic Antimicrobial Peptides
por: Man, DeDe Kwun-Wai, et al.
Publicado: (2018) -
Capreomycin is active against non-replicating M. tuberculosis
por: Heifets, Leonid, et al.
Publicado: (2005) -
The structures of the anti-tuberculosis antibiotics viomycin and capreomycin bound to the 70S ribosome
por: Stanley, Robin E., et al.
Publicado: (2010)